The U.S. Securities and Exchange Commission (SEC) continues to refine its enforcement priorities in ways that directly impact public companies, corporate boards, and shareholders.
Robbins LLP is Investigating Allegations that Driven Brands Holdings Inc. (DRVN) Made Material Errors in its Previously Issued Consolidated Financial Statements
Robbins LLP is Investigating Allegations that Soleno Therapeutics (SLNO) Misled Investors Regarding the Viability and Efficacy of its Phase 3 Clinical Trial for DCCR
Robbins LLP is Investigating Allegations that Eos Energy Enterprises, Inc. (EOSE) Misled Investors Regarding its Business Prospects
Robbins LLP is Investigating Allegations that Nektar Therapeutics (NKTR) Overstated the Prospects of its REZOLVE-AA Trial
Robbins LLP is Investigating Allegations that Aquestive Therapeutics, Inc. (AQST) Misled Investors Regarding Approval of Anaphylm
Robbins LLP is Investigating Allegations that Boston Scientific Corporation (BSX) Misled Investors Regarding Projected Revenue
Aaron Offringa, et al. v. dMY Sponsor II, LLC, et al., No. 2023-0929 (Del Ch. Feb. 23, 2026).
Robbins LLP is Investigating Allegations that Apollo Global Management, Inc. (APO) Failed to Disclose to Investors that Jeffrey Epstein was Involved in the Company’s Business
Attorney Advertising. Past results do not guarantee a similar outcome.
5060 Shoreham Pl., Ste. 300 San Diego, CA 92122
Disclaimer | Site Map | Privacy Policy
© 2025 – Robbins LLP
Protect yourStock Watch members receive free investment monitoring and notifications.
